Levesque LE, Hanley JA, Kezouh A, Suissa S
The published human data on CJC-1295 is thin
Each injection creates a sharp upward spike followed by a gradual decline
they are not FDA-approved for general consumer use, retail sale or recreational selfadministration and are dispensed exclusively through licensed pharmacies to patients under active clinical care
Although the insulinotropic effect of GIP is diminished in patients with type 2 diabetes, studies have found that GIP receptor agonists can induce a degree of weight loss and, when used in combination with GLP-1, can produce synergistic effects, enhancing blood glucose reduction and weight loss
Overview 5-Amino-1MQ is a research-grade peptide compound that supports laboratory investigation into the pathways outlined in current literature